The One Health approach for the management of an imported case of rabies in mainland Spain in 2013.

The One Health approach for the management of an imported case of rabies in mainland Spain in 2013. Euro Surveill. 2015;20(6) Authors: Perez de Diego A, Vigo M, Monsalve J, Escudero A PMID: 25695478 [PubMed - in process]
Source: Euro Surveill - Category: Infectious Diseases Authors: Tags: Euro Surveill Source Type: research

Related Links:

“In our ongoing commitment to address the supply shortages of rabies vaccine, we are making additional investments to increase production capacities to over 15 million doses annually,” added Krishna Ella, CMD, Bharat biotech International Ltd. The vaccine is presently manufactured at the WHO pre -qualified facility in Ankleshwar in Gujarat.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
Publication date: Available online 12 November 2019Source: Preventive Veterinary MedicineAuthor(s): Felipe Rocha, Ricardo Augusto DiasAbstractThe importance of the common vampire bat Desmodus rotundus for the transmission of the rabies virus does not lie solely in its ability to transmit this disease to other mammals, but also in its capacity to adapt to environmental and climatic changes, granting them a wide geographical distribution. Control of this disease is currently based on culling of the vampire bat and vaccination of the livestock. A transmission model incorporating geographic and behavioral determinants of the v...
Source: Preventive Veterinary Medicine - Category: Veterinary Research Source Type: research
(University of Melbourne) Researchers from Monash University and the University of Melbourne have found a way to stop the rabies virus shutting down the body's immune defence against it. In doing so they have solved a key scientific puzzle and have laid the foundation for the development of new anti-rabies vaccines.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
A Chinese maker of rabies vaccine that was fined $1.3 billion in a scandal that prompted a national crackdown on the industry says it has been declared bankrupt
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
CONCLUSIONS: The safety profile of RTS,S/AS01 in HIV-infected children was comparable to that of the comparator (meningococcal or rabies) vaccines. RTS,S/AS01 was immunogenic in HIV-infected children but antibody concentrations were lower than in children with an unknown or negative HIV status. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov: NCT00866619. PMID: 31708182 [PubMed - as supplied by publisher]
Source: Vaccine - Category: Allergy & Immunology Authors: Tags: Vaccine Source Type: research
Amy T. Gilbert Intensive efforts are being made to eliminate the raccoon variant of rabies virus (RABV) from the eastern United States and Canada. The United States Department of Agriculture (USDA) Wildlife Services National Rabies Management Program has implemented enhanced rabies surveillance (ERS) to improve case detection across the extent of the raccoon oral rabies vaccination (ORV) management area. We evaluated ERS and public health surveillance data from 2006 to 2017 in three northeastern USA states using a dynamic occupancy modeling approach. Our objectives were to examine potential risk corridors for RABV inc...
Source: Viruses - Category: Virology Authors: Tags: Article Source Type: research
Publication date: Available online 28 October 2019Source: Antiviral ResearchAuthor(s): Kentaro Yamada, Kazuko Noguchi, Kazunori Kimitsuki, Ryo Kaimori, Nobuo Saito, Takashi Komeno, Nozomi Nakajima, Yousuke Furuta, Akira NishizonoAbstractRabies virus (RABV) is a highly neurotropic virus and the causative agent of rabies, an encephalitis with an almost 100% case-fatality rate that remains incurable after the onset of symptoms. Favipiravir (T-705), a broad-spectrum antiviral drug against RNA viruses, has been shown to be effective against RABV in vitro but ineffective in vivo. We hypothesized that favipiravir is effective in ...
Source: Antiviral Therapy - Category: Virology Source Type: research
Listen: Mayo Clinic Radio 10/26/19 On the Mayo Clinic Radio podcast, Dr. Purna Kashyap, co-director of the Mayo Clinic Center for Individualized Medicine Microbiome Program, discusses gut microbiome research. Also on the podcast, Dr. Robert Jacobson, a Mayo Clinic pediatrician, shares what you need to know about bats and rabies. And Dr. Karen Swanson, a Mayo Clinic pulmonologist, shares [...]
Source: News from Mayo Clinic - Category: Databases & Libraries Source Type: news
Abstract Rabies virus (RABV) is a highly neurotropic virus and the causative agent of rabies, an encephalitis with an almost 100% case-fatality rate that remains incurable after the onset of symptoms. Favipiravir (T-705), a broad-spectrum antiviral drug against RNA viruses, has been shown to be effective against RABV in vitro but ineffective in vivo. We hypothesized that favipiravir is effective in infected mice when RABV replicates in the peripheral tissues/nerves but not after virus neuroinvasion. We attempted to clarify this point in this study using in vivo bioluminescence imaging. We generated a recombinant R...
Source: Antiviral Research - Category: Virology Authors: Tags: Antiviral Res Source Type: research
Bats play an important role in many ecosystems around the world. They are a major predator of night-flying insects, including pests that cost farmers billions of dollars annually. However, bats pose the biggest rabies threat in the U.S., according to the Centers for Disease Control and Prevention. Most bats are not rabid. However, because rabies [...]
Source: News from Mayo Clinic - Category: Databases & Libraries Source Type: news
More News: Health | Infectious Diseases | Rabies